Generalization With AI Navigation Using StaRt
Launched by NEW YORK UNIVERSITY · Mar 13, 2025
Trial Information
Current as of April 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This study will measure the effects of AI-guided home practice as a follow-up to participation in a study of technology-enhanced treatment for speech sound disorder affecting the American English "r" sound. Participants will sign a single consent form that covers their participation in the original VISIT study (in which they are randomized to receive biofeedback treatment in person or via telepractice) and and the follow-up GAINS study (in which participants are randomized to a follow-up period of treatment as usual \[TAU\] or treatment as usual plus an AI-guided maintenance program with bi...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • Must be between 9;0 and 17;11 (years;months) old at the time of enrollment.
- • Must speak English as the dominant or equally dominant language
- • Must have begun learning English by age 3, per parent report.
- • Must hear a rhotic dialect of English from at least one speaker in the home if the home language is English.
- • Must pass a pure-tone hearing screening.
- • Must pass a brief examination of oral structure and function.
- • Must demonstrate age-appropriate receptive and expressive language abilities on the Clinical Evaluation of Language Fundamentals-5 (CELF-5).
- • Must have access to a laptop or desktop computer for study sessions.
- • Must have home wifi sufficient to support video calls in the event of randomization to the telepractice condition.
- • Must have completed participation in the VISIT randomized controlled trial.
- • Must score at least 60% correct in at least one treatment session during the related previous study, VISIT.
- Exclusion Criteria:
- • • Must not exhibit voice or fluency disorder of a severity judged likely to interfere with the ability to participate in study activities.
- • Must not currently have orthodontia that crosses the palate and cannot be removed.
- • Must not have history of permanent hearing loss.
- • Must not have an existing diagnosis of developmental disability such as cerebral palsy or Down Syndrome.
- • Must not have history of major brain injury, surgery, or stroke in the past year.
- • Must not have epilepsy with active seizure incidents with in the past 6 months.
- • Must not show clinically significant signs of apraxia of speech or dysarthria.
About New York University
New York University (NYU) is a prestigious research institution renowned for its commitment to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust infrastructure and a diverse team of leading experts, NYU conducts cutting-edge research across various therapeutic areas, focusing on translating scientific discoveries into effective treatments. The university fosters collaboration among multidisciplinary teams and engages with a broad patient population, ensuring that its trials adhere to the highest ethical standards and regulatory requirements. NYU's dedication to excellence in research and education positions it as a key contributor to the advancement of healthcare and clinical practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Syracuse, New York, United States
Bloomfield, New Jersey, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported